In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: biodegradation and tissue reactions.

The in vivo tissue reactions and biodegradations of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx), poly(lactide) (PLA), poly(3-hydroxybutyrate) (PHB), blends of PHBHHx (X) and poly(ethylene glycol) (PEG) (E) with ratios of 1:1 (E1X1) and 1:5 (E1X5), respectively, were evaluated by subcutaneous implantation in rabbits. Results revealed that the degradation rate increased in the order of PHB < PHBHHx < PLA. During the implantation period, crystallinity of PHBHHx increased from 19% to 22% and then dropped to 14%. Gel permeation chromatography (GPC) displayed increasing polydispersity and typical bimodal distribution from 3 to 6 months. The above results suggested that rapid PHBHHx degradation occurred in amorphous region rather than in crystalline region. While the in vivo hydrolysis of PHB was found to start from a random chain scission both in amorphous and crystalline regions of the polymer matrix, as demonstrated by its hydrolysis process accompanied by a decrease in molecular weight with unimodal distribution and relatively narrow polydispersity. Compared to pure PHBHHx, PHBHHx-PEG blends showed accelerated weight loss of PHBHHx with weak molecular weight reduction. In general, PHBHHx elicited a very mild tissue response during implantation lasting 6 months compared with relative acute immunological reactions observed among PHB and PLA objects, respectively. Pronounced tissue responses were observed in the capsule surrounding E1X1 and E1X5 as characterized by the presence of lymphocytes, eosinophils and vascularization, which might be resulted from the continuous leaching of PEG.

[1]  A. Bantjes,et al.  In vivo testing of crosslinked polyethers. I. Tissue reactions and biodegradation. , 1996, Journal of biomedical materials research.

[2]  E. Martuscelli,et al.  Review Properties of blends and composites based on poly(3-hydroxy)butyrate (PHB) and poly(3-hydroxybutyrate-hydroxyvalerate) (PHBV) copolymers , 2000 .

[3]  Y. Tokiwa,et al.  Review Degradation of microbial polyesters , 2004, Biotechnology Letters.

[4]  Guoqiang Chen,et al.  The application of polyhydroxyalkanoates as tissue engineering materials. , 2005, Biomaterials.

[5]  F. Schué,et al.  Modification of the biocompatible and haemocompatible properties of polymer substrates by plasma-deposited fluorocarbon coatings. , 1992, Biomaterials.

[6]  C. Blitterswijk,et al.  Evaluation of polylactide monomers in an in vitro biocompatibility assay , 1994 .

[7]  H. Seliger,et al.  Synthesis and characterization of biodegradable poly(ester‐urethanes) based on bacterial poly(R‐3‐hydroxybutyrate) , 2002 .

[8]  David P. Martin,et al.  PHA applications: addressing the price performance issue: I. Tissue engineering. , 1999, International journal of biological macromolecules.

[9]  R. Farris,et al.  The mechanical properties of a thermoplastic elastomer produced by the bacterium Pseudomonas oleovorans , 1992 .

[10]  A. Pennings,et al.  General crystallization behaviour of poly(l-lactic acid) , 1980 .

[11]  Qiong Wu,et al.  Effect of 3-hydroxyhexanoate content in poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) on in vitro growth and differentiation of smooth muscle cells. , 2006, Biomaterials.

[12]  Guoqiang Chen,et al.  Biodegradation studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) , 2004 .

[13]  S. Perren,et al.  Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). , 1993, Journal of biomedical materials research.

[14]  P. Barham,et al.  Crystallization and morphology of a bacterial thermoplastic: poly-3-hydroxybutyrate , 1984 .

[15]  Katrin Sternberg,et al.  In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate). , 2002, Biomaterials.

[16]  W C de Bruijn,et al.  In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles. , 1995, Biomaterials.

[17]  A. Anderson,et al.  Occurrence, metabolism, metabolic role, and industrial uses of bacterial polyhydroxyalkanoates. , 1990, Microbiological reviews.

[18]  Terumi Saito,et al.  In vivo and in vitro degradation of poly(3-hydroxybutyrate) in pat , 1991 .

[19]  Guoqiang Chen,et al.  Enhanced vascular-related cellular affinity on surface modified copolyesters of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx). , 2005, Biomaterials.

[20]  J. Kohn,et al.  Comparative histological evaluation of new tyrosine-derived polymers and poly (L-lactic acid) as a function of polymer degradation. , 1998, Journal of biomedical materials research.